Subscribe

Osteonecrosis of the Jaw Associated with Anti-Angiogenetic Targeted Therapy (Sunitinib, Bevacizumab, etc)

Specialty:

Neurology, Psychiatry, Ophthalmology & Otolaryngology
Orthopedic Surgery, Sports Medicine & Rehabilitation
Clinical Pharmacology & Toxicology

Objective:

ICD-10:

Description:

Cancer therapy with an anti-angiogenetic targeted therapy can result in osteonecrosis of the jaw. This has been most often reported in patients with advanced renal cancer.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone